(Q38106620)

29 August 2017

title

The role of vitamin D supplementation in patients with rheumatic diseases (English)

1 reference

29 August 2017

0 references

Bo Abrahamsen

1

1 reference

29 August 2017

Nicholas C Harvey

series ordinal

2

1 reference

29 August 2017

language of work or name

English

0 references

publication date

14 May 2013

1 reference

Nature Reviews Rheumatology

29 August 2017

published in

1 reference

29 August 2017

volume

9

1 reference

29 August 2017

issue

7

1 reference

29 August 2017

page(s)

411-422

1 reference

Vitamin D metabolism in the kidney: regulation by phosphorus and fibroblast growth factor 23.

29 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.71

Targeted inactivation of vitamin D hydroxylases in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.71

Extrarenal expression of the 25-hydroxyvitamin D-1-hydroxylase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.71

Suppressive effect of 1alpha,25-dihydroxyvitamin D3 on type I IFN-mediated monocyte differentiation into dendritic cells: impairment of functional activities and chemotaxis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.71

Cutting edge: 1,25-dihydroxyvitamin D3 is a direct inducer of antimicrobial peptide gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.71

Effects of vitamin D on the peripheral adaptive immune system: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.71

Vitamin D: some perspective please

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.71

Determinants of vitamin D status in a general population of Danish adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.71

Hypovitaminosis D in developing countries-prevalence, risk factors and outcomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.71

Measurement of 25-hydroxyvitamin D in the clinical laboratory: current procedures, performance characteristics and limitations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.71

Use of calcium or calcium in combination with vitamin D supplementation to prevent fractures and bone loss in people aged 50 years and older: a meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.71

Patient level pooled analysis of 68 500 patients from seven major vitamin D fracture trials in US and Europe

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.71

A pooled analysis of vitamin D dose requirements for fracture prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.71

IOM committee members respond to Endocrine Society vitamin D guideline

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.71

Evaluation, Treatment, and Prevention of Vitamin D Deficiency: an Endocrine Society Clinical Practice Guideline

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.71

Annual injection of vitamin D and fractures of aged bones.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.71

Vitamin D and calcium supplementation prevents osteoporotic fractures in elderly community dwelling residents: a pragmatic population-based 3-year intervention study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.71

Endogenous hormones and the risk of hip and vertebral fractures among older women. Study of Osteoporotic Fractures Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.71

American College of Rheumatology 2010 recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.71

Calcium and vitamin D3 supplementation prevents bone loss in the spine secondary to low-dose corticosteroids in patients with rheumatoid arthritis. A randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.71

Efficacy of bazedoxifene in reducing new vertebral fracture risk in postmenopausal women with osteoporosis: results from a 3-year, randomized, placebo-, and active-controlled clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.71

Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.71

The impact of dietary calcium intake and vitamin D status on the effects of zoledronate

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.71

VDR and CYP27B1 are expressed in C2C12 cells and regenerating skeletal muscle: potential role in suppression of myoblast proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.71

Is the vitamin d receptor found in muscle?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.71

Where is the vitamin D receptor?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.71

Association between 25-hydroxy vitamin D levels, physical activity, muscle strength and fractures in the prospective population-based OPRA Study of Elderly Women

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.71

Annual high-dose oral vitamin D and falls and fractures in older women: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.71

Clinical review: The effect of vitamin D on falls: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.71

Vitamin D levels and disease status in Texas patients with systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.71

Vitamin D insufficiency in Brazilian patients with SLE: prevalence, associated factors, and relationship with activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.71

Associations between vitamin D receptor polymorphisms and susceptibility to rheumatoid arthritis and systemic lupus erythematosus: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.71

The immunopathological role of vitamin D in patients with SLE: data from a single centre registry in Hungary

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.71

Evidence that abnormally large seasonal declines in vitamin D status may trigger SLE flare in non-African Americans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.71

The relation between acute changes in the systemic inflammatory response and plasma 25-hydroxyvitamin D concentrations after elective knee arthroplasty.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.71

Vitamin D deficiency in patients with cutaneous lupus erythematosus is prevalent throughout the year

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.71

Serum 25-hydroxyvitamin D levels in patients with cutaneous lupus erythematosus in a Mediterranean region

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.71

Photoprotective behaviour and sunscreen use: impact on vitamin D levels in cutaneous lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.71

Vitamin D intake and risks of systemic lupus erythematosus and rheumatoid arthritis in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.71

Changes in vitamin D levels in patients with systemic lupus erythematosus: Effects on fatigue, disease activity, and damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.71

The use of micronutrient supplements is not associated with better quality of life and disease activity in Canadian patients with systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.71

Low serum levels of vitamin D in idiopathic inflammatory myopathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.71

Vitamin D deficiency in a cohort of patients with systemic scleroderma from the south of Spain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.71

Vitamin D deficiency in rheumatoid arthritis: prevalence, determinants and associations with disease activity and disability

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.71

Plasma 25,OH vitamin D concentrations are not associated with rheumatoid arthritis (RA)-related autoantibodies in individuals at elevated risk for RA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.71

Vitamin D status and its associations with disease activity and severity in African Americans with recent-onset rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.71

Vitamin D intake is inversely associated with rheumatoid arthritis: results from the Iowa Women's Health Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.71

Vitamin D receptor genotype is associated with radiographic osteoarthritis at the knee.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.71

The relative roles of intragenic polymorphisms of the vitamin d receptor gene in lumbar spine degeneration and bone density

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.71

Vitamin D receptor gene polymorphisms and susceptibility of hand osteoarthritis in Finnish women

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.71

Identification of new susceptibility loci for osteoarthritis (arcOGEN): a genome-wide association study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.71

Association of 25-hydroxyvitamin D with prevalent osteoarthritis of the hip in elderly men: the osteoporotic fractures in men study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.71

Serum vitamin D levels and incident changes of radiographic hip osteoarthritis: a longitudinal study. Study of Osteoporotic Fractures Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.71

Vitamin D status, bone mineral density, and the development of radiographic osteoarthritis of the knee: The Rotterdam Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.71

Low levels of vitamin D and worsening of knee osteoarthritis: Results of two longitudinal studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.71

Association of vitamin D status with knee pain and radiographic knee osteoarthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.71

Relationship between disease activity and serum levels of vitamin D metabolites and parathyroid hormone in ankylosing spondylitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.71

Discovery of candidate serum proteomic and metabolomic biomarkers in ankylosing spondylitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.71

Seasonal variation in vitamin D levels in psoriatic arthritis patients from different latitudes and its association with clinical outcomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.71

Treatment of psoriatic arthritis with oral 1,25-dihydroxyvitamin D3: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.71

An excess of widespread pain among South Asians: are low levels of vitamin D implicated?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.71

Musculoskeletal pain is associated with very low levels of vitamin D in men: results from the European Male Ageing Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.71

Prevention of glucocorticoid-induced osteopenia: effect of oral 25-hydroxyvitamin D and calcium

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.71

Diffuse musculoskeletal pain is not associated with low vitamin D levels or improved by treatment with vitamin D.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.71

Renal versus extrarenal activation of vitamin D in relation to atherosclerosis, arterial stiffening, and hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.71

25-Hydroxyvitamin D deficiency is associated with fatal stroke among whites but not blacks: The NHANES-III linked mortality files.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.71

Vitamin D levels predict all-cause and cardiovascular disease mortality in subjects with the metabolic syndrome: the Ludwigshafen Risk and Cardiovascular Health (LURIC) Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.71

Vitamin D insufficiency and health outcomes over 5 y in older women

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.71

Is vitamin D deficiency a risk factor for ischemic heart disease in patients with established cardiovascular disease? 10-year follow-up of the Nova Scotia Health Survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.71

Vitamin D status and outcomes in heart failure patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.71

Calcium/vitamin D supplementation and cardiovascular events

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.71

Effect of calcium supplements on risk of myocardial infarction and cardiovascular events: meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.71

Calcium plus vitamin D supplementation and the risk of fractures

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.71

Serum 25-hydroxyvitamin D and cancer mortality in the NHANES III study (1988-2006)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.71

Vitamin D With or Without Calcium Supplementation for Prevention of Cancer and Fractures: An Updated Meta-analysis for the U.S. Preventive Services Task Force

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.71

Epidemiology of sarcoidosis in Japan.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.71

Hypercalcemia in granulomatous disorders: a clinical review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.71

Calcium and Vitamin D in Sarcoidosis: How to Assess and Manage

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.71

Elevated 1, 25-dihydroxyvitamin D levels are associated with protracted treatment in sarcoidosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.71

Calcium supplements with or without vitamin D and risk of cardiovascular events: reanalysis of the Women's Health Initiative limited access dataset and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.71

Do calcium plus vitamin D supplements increase cardiovascular risk?

21 January 2018

2 references

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.71

21 January 2018

12 December 2020

Relationship of Focal Erosions, Bone Mineral Density, and Parathyroid Hormone in Rheumatoid Arthritis

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.71

Seasonal 25-hydroxyvitamin D changes in British postmenopausal women at 57 degrees N and 51 degrees N: a longitudinal study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.71

Vitamin D and falls. Time for a moratorium on vitamin D meta-analyses?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.71

Recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis. American College of Rheumatology Task Force on Osteoporosis Guidelines

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.71

Recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis: 2001 update. American College of Rheumatology Ad Hoc Committee on Glucocorticoid-Induced Osteoporosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.71

Prevention of Corticosteroid Osteoporosis -- A Comparison of Calcium, Calcitriol, and Calcitonin

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.71

Alendronate or alfacalcidol in glucocorticoid-induced osteoporosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.71

Clodronate reduces the incidence of fractures in community-dwelling elderly women unselected for osteoporosis: results of a double-blind, placebo-controlled randomized study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.71

Vitamin D and falls--are intermittent, high doses better?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.71

Effects of three-monthly oral 150,000 IU cholecalciferol supplementation on falls, mobility, and muscle strength in older postmenopausal women: a randomized controlled trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.71

Vitamin D3 metabolism in patients with rheumatic diseases: Low serum levels of 25-hydroxyvitamin D3 in patients with systemic lupus erythematosus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.71

Reduced serum concentrations of 25-hydroxy vitamin D in Egyptian patients with systemic lupus erythematosus: relation to disease activity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.71

Fatigue, muscle strength and vitamin D status in women with systemic lupus erythematosus compared with healthy controls

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.71

Vitamin D deficiency as marker for disease activity and damage in systemic lupus erythematosus: a comparison with anti-dsDNA and anti-C1q

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.71

Hypovitaminosis D and disease: consequence rather than cause?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.71

Significantly decreased serum 25-hydroxyvitamin d levels in a large german systemic sclerosis cohort

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.71

Vitamin D deficiency and insufficiency in 2 independent cohorts of patients with systemic sclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.71

Very low levels of vitamin D in systemic sclerosis patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.71

Double-blind, placebo-controlled study of oral calcitriol for the treatment of localized and systemic scleroderma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.71

Rheumatoid arthritis: circadian and circannual rhythms in RA

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.71

Prevalence of vitamin D insufficiency/deficiency in rheumatoid arthritis and associations with disease severity and activity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.71

The relationship between vitamin D and disease activity and functional health status in rheumatoid arthritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.71

Vitamin D receptor gene polymorphisms and osteoarthritis of the hand, hip, and knee: acase-control study in Japan

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.71

Serum levels of vitamin D, sunlight exposure, and knee cartilage loss in older adults: the Tasmanian older adult cohort study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.71

Associations of vitamin d binding protein gene polymorphisms with the development of peripheral arthritis and uveitis in ankylosing spondylitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.71

Association between nonspecific skeletal pain and vitamin D deficiency

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.71

Vitamin D for the treatment of chronic painful conditions in adults

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.71

Effects of large doses of calciferol on patients with rheumatoid arthritis. A double-blind clinical trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.71

Evidence of harm is unconvincing

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.71

Calcium and vitamin D supplementation and cardiovascular disease: quo vadis?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.71

25-Hydroxyivitamin D3 levels in patients with systemic lupus erythematosus and its association with clinical parameters and laboratory tests

31 March 2020

1 reference

12 December 2020

Vitamin D deficiency in fibromyalgia.

1 reference

12 December 2020

Circannual vitamin d serum levels and disease activity in rheumatoid arthritis: Northern versus Southern Europe.

1 reference

12 December 2020

Validation of a dietary vitamin D questionnaire using multiple diet records and the block 98 health habits and history questionnaire in healthy postmenopausal women in northern California

1 reference

12 December 2020

The Biological Activity and Metabolism of 24,25-Dihydroxyvitamin D3

1 reference

12 December 2020

[A double blind trial of alfacalcidol on patients with rheumatoid arthritis (RA)]

1 reference

12 December 2020

Disease modifying and immunomodulatory effects of high dose 1 alpha (OH) D3 in rheumatoid arthritis patients

1 reference

12 December 2020

Relationships among vitamin D, disease activity, pain and disability in rheumatoid arthritis.

1 reference

12 December 2020

1,24,25-Trihydroxyvitamin D3. A metabolite of vitamin D3 effective on intestine.

1 reference

12 December 2020

Vitamin D and calcium in the prevention of corticosteroid induced osteoporosis: a 3 year followup

1 reference

12 December 2020

Identifiers

DOI

10.1038/NRRHEUM.2013.71

1 reference

Dimensions Publication ID

29 August 2017

1038675116

0 references

1 reference